VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines.

Khaitan A, Lindsey JC, Capparelli EV, Tierney C, Coletti A, Perlowski C, Yin DE, Smith MEB, Spiegel HML, Majji S, Moye J, Gama L, Koup RA, Lin BC, McDermott AB, Purdue L, Krotje C, Harding PA, Cotton MF, Costello D, Petropoulos CJ, Reeves JD, Mallewa M, Chihana R, Kamthunzi P, Mbengeranwa TG, Masheto G, Santos Cruz ML, Pilotto JH, Ponatshego PL, Persaud D, McFarland EJ, IMPAACT 2008 Team

Open source

DOI
10.1126/scitranslmed.adr4509
Published
2026 May 6
Container
Science translational medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1126/scitranslmed.adr4509,
  title = {VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines.},
  author = {Khaitan A and Lindsey JC and Capparelli EV and Tierney C and Coletti A and Perlowski C and Yin DE and Smith MEB and Spiegel HML and Majji S and Moye J and Gama L and Koup RA and Lin BC and McDermott AB and Purdue L and Krotje C and Harding PA and Cotton MF and Costello D and Petropoulos CJ and Reeves JD and Mallewa M and Chihana R and Kamthunzi P and Mbengeranwa TG and Masheto G and Santos Cruz ML and Pilotto JH and Ponatshego PL and Persaud D and McFarland EJ and IMPAACT 2008 Team},
  year = {2026},
  journal = {Science translational medicine},
  doi = {10.1126/scitranslmed.adr4509},
  url = {https://doi.org/10.1126/scitranslmed.adr4509}
}

RIS

TY  - JOUR
TI  - VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines.
AU  - Khaitan A
AU  - Lindsey JC
AU  - Capparelli EV
AU  - Tierney C
AU  - Coletti A
AU  - Perlowski C
AU  - Yin DE
AU  - Smith MEB
AU  - Spiegel HML
AU  - Majji S
AU  - Moye J
AU  - Gama L
AU  - Koup RA
AU  - Lin BC
AU  - McDermott AB
AU  - Purdue L
AU  - Krotje C
AU  - Harding PA
AU  - Cotton MF
AU  - Costello D
AU  - Petropoulos CJ
AU  - Reeves JD
AU  - Mallewa M
AU  - Chihana R
AU  - Kamthunzi P
AU  - Mbengeranwa TG
AU  - Masheto G
AU  - Santos Cruz ML
AU  - Pilotto JH
AU  - Ponatshego PL
AU  - Persaud D
AU  - McFarland EJ
AU  - IMPAACT 2008 Team
PY  - 2026
JO  - Science translational medicine
DO  - 10.1126/scitranslmed.adr4509
UR  - https://doi.org/10.1126/scitranslmed.adr4509
ER  - 

APA

A, K., JC, L., EV, C., C, T., A, C., C, P., DE, Y., MEB, S., HML, S., S, M., J, M., L, G., RA, K., BC, L., AB, M., L, P., C, K., PA, H., MF, C., D, C., CJ, P., JD, R., M, M., R, C., P, K., TG, M., G, M., ML, S. C., JH, P., PL, P., D, P., EJ, M., & Team, I. 2. (2026). VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines.. Science translational medicine. https://doi.org/10.1126/scitranslmed.adr4509

Source records